Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1972 Mar 11;1(5801):649–651. doi: 10.1136/bmj.1.5801.649

Assessment of the Need for Continued Oral Therapy in Diabetics

A M Tomkins, Arnold Bloom
PMCID: PMC1787772  PMID: 5015290

Abstract

Hypoglycaemic agents were replaced by placebos in diabetic patients attending a hospital clinic. Of 62 patients observed, 43 (69%) relapsed within six months but blood sugar control remained unchanged in 19 (31%) during the period of observation.

Full text

PDF
649

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CROWLEY M. F., WOLFF F. W., BLOOM A. Tolbutamide in diabetes; some clinical and biochemical studies. Br Med J. 1957 Aug 10;2(5040):327–331. doi: 10.1136/bmj.2.5040.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Constam G. R. Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous? Diabetologia. 1971 Aug;7(4):237–239. doi: 10.1007/BF01211874. [DOI] [PubMed] [Google Scholar]
  3. Keen H., Rose G., Pyke D. A., Boyns D., Chlouverakis C. Blood-sugar and arterial disease. Lancet. 1965 Sep 11;2(7411):505–508. doi: 10.1016/s0140-6736(65)91470-4. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES